These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 23738914)

  • 1. Streptomyces cytochromes P450: applications in drug metabolism.
    Lamb DC; Waterman MR; Zhao B
    Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1279-94. PubMed ID: 23738914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel cytochrome P450 mono-oxygenase from Streptomyces platensis resembles activities of human drug metabolizing P450s.
    Worsch A; Eggimann FK; Girhard M; von Bühler CJ; Tieves F; Czaja R; Vogel A; Grumaz C; Sohn K; Lütz S; Kittelmann M; Urlacher VB
    Biotechnol Bioeng; 2018 Sep; 115(9):2156-2166. PubMed ID: 29943426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450-mediated metabolism in brain: functional roles and their implications.
    Ravindranath V; Strobel HW
    Expert Opin Drug Metab Toxicol; 2013 May; 9(5):551-8. PubMed ID: 23330950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome p450 and chemical toxicology.
    Guengerich FP
    Chem Res Toxicol; 2008 Jan; 21(1):70-83. PubMed ID: 18052394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolism of xenobiotics: beneficial and adverse effects].
    Mansuy D
    Biol Aujourdhui; 2013; 207(1):33-7. PubMed ID: 23694723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding electron transport systems of Streptomyces cytochrome P450.
    Chun YJ; Shimada T; Waterman MR; Guengerich FP
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1183-5. PubMed ID: 17073781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of carcinogen-metabolizing cytochromes P450 by phytochemicals in humans.
    Baer-Dubowska W; Szaefer H
    Expert Opin Drug Metab Toxicol; 2013 Aug; 9(8):927-41. PubMed ID: 23634851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymes involved in the metabolism of the carcinogen 2-nitroanisole: evidence for its oxidative detoxication by human cytochromes P450.
    Miksanová M; Sulc M; Rýdlová H; Schmeiser HH; Frei E; Stiborová M
    Chem Res Toxicol; 2004 May; 17(5):663-71. PubMed ID: 15144223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-cytochrome P450-mediated bioactivation and its toxicological relevance.
    Gan J; Ma S; Zhang D
    Drug Metab Rev; 2016 Nov; 48(4):473-501. PubMed ID: 27533622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes.
    Lee IS; Kim D
    Arch Pharm Res; 2011 Nov; 34(11):1799-816. PubMed ID: 22139682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel advances in cytochrome P450 research.
    Singh D; Kashyap A; Pandey RV; Saini KS
    Drug Discov Today; 2011 Sep; 16(17-18):793-9. PubMed ID: 21864709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new cytochrome P450 belonging to the 107L subfamily is responsible for the efficient hydroxylation of the drug terfenadine by Streptomyces platensis.
    Lombard M; Salard I; Sari MA; Mansuy D; Buisson D
    Arch Biochem Biophys; 2011 Apr; 508(1):54-63. PubMed ID: 21241658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in molecular modeling of human cytochrome P450 polymorphism.
    Martiny VY; Miteva MA
    J Mol Biol; 2013 Nov; 425(21):3978-92. PubMed ID: 23856621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of enzyme induction and enzyme inhibition in humans: toxicological implications.
    Park BK; Kitteringham NR
    Xenobiotica; 1990 Nov; 20(11):1171-85. PubMed ID: 2275213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human drug metabolizing enzymes. I. Oxidative enzymes].
    Vereczkey L; Monostory K; Veres Z
    Acta Pharm Hung; 1998 Sep; 68(5):276-83. PubMed ID: 9805813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 and Non-Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics.
    Foti RS; Dalvie DK
    Drug Metab Dispos; 2016 Aug; 44(8):1229-45. PubMed ID: 27298339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative activities of heterologously expressed CYP107B1 and CYP105D1 in whole-cell biotransformation using Streptomyces lividans TK24.
    Ueno M; Yamashita M; Hashimoto M; Hino M; Fujie A
    J Biosci Bioeng; 2005 Nov; 100(5):567-72. PubMed ID: 16384798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450s in the development of target-based anticancer drugs.
    Purnapatre K; Khattar SK; Saini KS
    Cancer Lett; 2008 Jan; 259(1):1-15. PubMed ID: 18053638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel extrahepatic cytochrome P450s.
    Karlgren M; Miura S; Ingelman-Sundberg M
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):57-61. PubMed ID: 15987645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety assessment of drug metabolites: implications of regulatory guidance and potential application of genetically engineered mouse models that express human P450s.
    Powley MW; Frederick CB; Sistare FD; DeGeorge JJ
    Chem Res Toxicol; 2009 Feb; 22(2):257-62. PubMed ID: 19170595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.